Author:
James Beth,Reesaul Hishikha,Kashif Sidra,Behruznia Mahboobeh,Meehan Conor J.,Domingo-Sananes Maria Rosa,Hubbard Alasdair T. M.
Abstract
AbstractTrimethoprim is recommended as a first-line treatment of urinary tract infections (UTIs) in the UK. In 2018, 31.4% ofEscherichia coliisolated from UTIs in England were trimethoprim resistant, leading to overreliance on other first and second-line antibiotics. Here, we assessed whether prior selection with trimethoprim results in collateral effects to other antibiotics recommended for the treatment of UTIs. As collateral effects, we considered changes in susceptibility, mutation-selection window and population establishment probability. We selected 10 trimethoprim-resistant derivatives from three clinical isolates of uropathogenicEscherichia coli.We found that mutations conferring trimethoprim resistance did not have any collateral effects to fosfomycin. In contrast, resistance to trimethoprim resulted in decreased susceptibility (collateral resistance) to nitrofurantoin, below the clinical breakpoint, and narrowed the mutation-selection window thereby reducing the maximum concentration for selection of nitrofurantoin resistance mutations. Our analyses demonstrate that multiple collateral responses should be accounted for when predicting and optimising antibiotic use, limiting future AMR emergence.
Publisher
Cold Spring Harbor Laboratory
Reference36 articles.
1. Disease burden and long-term trends of urinary tract infections: A worldwide report;Frontiers in public health,2022
2. Global, regional, and national burden of urinary tract infections from 1990 to 2019: an analysis of the global burden of disease study 2019;World J Urol,2022
3. The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis. The Lancet;Public health,2022
4. Urinary tract infections: epidemiology, mechanisms of infection and treatment options
5. Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998–2016: a study of electronic health records